Ftse Mib
34.660,38
-0,50%
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
NASDAQ
17.133,13
-0,23%
Bitcoin
69.421,26
0,13%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Thimble Point Acquisition Corporation (THMA) Thimble Point Acquisition Corporation (THMA) Notizie

THMA

Thimble Point Acquisition (THMA)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:THMA
DataOraFonteTitoloSimboloCompagnia
02/05/202319:37Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:THMAThimble Point Acquisition Corporation
12/04/202322:34Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:THMAThimble Point Acquisition Corporation
10/04/202322:37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:THMAThimble Point Acquisition Corporation
31/03/202322:04Edgar (US Regulatory)Annual Report (10-k)NASDAQ:THMAThimble Point Acquisition Corporation
09/02/202322:43Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:THMAThimble Point Acquisition Corporation
24/01/202322:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:THMAThimble Point Acquisition Corporation
10/01/202322:21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:THMAThimble Point Acquisition Corporation
04/01/202322:21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:THMAThimble Point Acquisition Corporation
04/01/202312:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:THMAThimble Point Acquisition Corporation
03/01/202313:38Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:THMAThimble Point Acquisition Corporation
14/11/202223:53Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:THMAThimble Point Acquisition Corporation
16/06/202222:11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:THMAThimble Point Acquisition Corporation
02/05/202222:06Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:THMAThimble Point Acquisition Corporation
02/05/202222:06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:THMAThimble Point Acquisition Corporation
29/03/202212:07Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:THMAThimble Point Acquisition Corporation
14/02/202212:35Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:THMAThimble Point Acquisition Corporation
23/12/202122:41Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:THMAThimble Point Acquisition Corporation
13/12/202122:31Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:THMAThimble Point Acquisition Corporation
13/12/202122:17Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:THMAThimble Point Acquisition Corporation
03/12/202122:12Business WirePear Therapeutics and Thimble Point Announce Closing of Business Combination to Create Publicly Traded Prescription Digital Therapeutics CompanyNASDAQ:THMAThimble Point Acquisition Corporation
30/11/202123:05Edgar (US Regulatory)Sec Staff Action/letter (sec Staff)NASDAQ:THMAThimble Point Acquisition Corporation
23/11/202114:00Business WirePear Therapeutics to Participate in Evercore ISI Fourth Annual HealthCONx ConferenceNASDAQ:THMAThimble Point Acquisition Corporation
22/11/202122:52Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:THMAThimble Point Acquisition Corporation
22/11/202114:00Business WirePear Therapeutics Receives FDA Breakthrough Device Designation for Prescription Digital Therapeutic Candidate to Treat Alcohol Use DisorderNASDAQ:THMAThimble Point Acquisition Corporation
15/11/202114:02Business WirePear Therapeutics Provides 2021 Business Update and Reaffirms Full Year 2021 Revenue GuidanceNASDAQ:THMAThimble Point Acquisition Corporation
15/11/202114:00Business WireThimble Point and Pear Therapeutics Announce Additional $50 Million in Committed Capital to Fund Business PlanNASDAQ:THMAThimble Point Acquisition Corporation
09/11/202114:00Business WirePear Therapeutics Announces Inclusion of reSET® and reSET-O® on the November 2021 MassHealth Drug List Summary Update and MassHealth Non-Drug Product ListNASDAQ:THMAThimble Point Acquisition Corporation
08/11/202122:05Business WirePear Therapeutics to Participate in the BTIG Digital Health ForumNASDAQ:THMAThimble Point Acquisition Corporation
25/10/202115:21Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:THMAThimble Point Acquisition Corporation
09/09/202114:35Business WirePear and Thimble Point Announce Nominees to Board of DirectorsNASDAQ:THMAThimble Point Acquisition Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:THMA

La tua Cronologia

LSE
ROS
Ramco Energy
LSE
54QU
Silverstone 70
BIT
UB5LZ7
Unicredit Bank
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network